• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ARTHROSURFACE, INC. HEMICAP® MTP RESURFACING HEMI-ARTHROPLASTY; MTP HEMI-TOE PROSTHESIS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ARTHROSURFACE, INC. HEMICAP® MTP RESURFACING HEMI-ARTHROPLASTY; MTP HEMI-TOE PROSTHESIS Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem No Code Available (3191)
Event Type  Injury  
Manufacturer Narrative
The manufacturer is currently investigating the issue and will submit the results in a supplemental report.
 
Event Description
In a patient, bone resorption was noticed behind the toe hemicap implant during revision surgery.
 
Manufacturer Narrative
The patient was revised to a fusion and the surgeon was satisfied with the outcome.No additional adverse events have been reported from this event.Since no pathology testing was conducted, it is unknown whether a tissue infection was present.Also, the revision surgeon is unaware of patient's sensitivity to metals and no testing was performed in this regard.The cause of the reported event cannot be determined from the information available and without device evaluation.Since the part and lot information is not available, a review of the manufacturing records of devices in question could not be performed.It is possible that the reported bone resorption could be related to an adverse patient reaction to the materials implanted.Several factors such as stress/ physical loads on the implants, vascularity of the implantation site, surgical techniques employed during implantation, patient factors (such as age, current state of the immune system, bone quality, and sensitivity to device materials), and patient post-op compliance to rehabilitation procedures etc., can have impact on the functional effectiveness of the implanted devices.The package insert provided with the product states that this type of event can occur.The risk associated with the event has been documented in the design file with appropriate control measures.The implant materials and combinations have decades of history for use in joint replacement applications.Also, the implant materials have been evaluated for biocompatibility to demonstrate safety for intended purposes.If additional relevant information is received, a follow-up report will be submitted.The results of the investigation could not verify or identify any product contribution to the reported event with the information provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HEMICAP® MTP RESURFACING HEMI-ARTHROPLASTY
Type of Device
MTP HEMI-TOE PROSTHESIS
Manufacturer (Section D)
ARTHROSURFACE, INC.
28 forge parkway
franklin MA 02038
MDR Report Key7386770
MDR Text Key104027447
Report Number3004154314-2018-00008
Device Sequence Number1
Product Code KWD
Combination Product (y/n)N
PMA/PMN Number
K131377
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Type of Report Initial,Followup
Report Date 03/01/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/30/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Date Manufacturer Received03/01/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age54 YR
-
-